|
| 28522603 | SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells. | Clin Cancer Res | 2017 |
| 28340323 | A key to the backdoor into the castle: The clinical ramifications of immunoediting driven by antigenic competition. | Hum Vaccin Immunother | 2017 |
| 28522603 | SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells. | Clin Cancer Res | 2017 |
| 28340323 | A key to the backdoor into the castle: The clinical ramifications of immunoediting driven by antigenic competition. | Hum Vaccin Immunother | 2017 |
| 27650546 | CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network. | Oncotarget | 2016 |
| 27650546 | CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network. | Oncotarget | 2016 |
| 25633867 | Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features. | Cancer Prev Res (Phila) | 2015 |
| 25633867 | Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features. | Cancer Prev Res (Phila) | 2015 |
| 26046389 | Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma. | Cancer Biol Ther | 2015 |
| 26046389 | Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma. | Cancer Biol Ther | 2015 |
| 24351288 | Activation of the NOTCH pathway in head and neck cancer. | Cancer Res | 2014 |
| 25483649 | Active specific immunotherapy: using tumor heterogeneity to successfully fight cancer. | Hum Vaccin Immunother | 2014 |
| 24351288 | Activation of the NOTCH pathway in head and neck cancer. | Cancer Res | 2014 |
| 25081901 | A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. | Ann Oncol | 2014 |
| 25483649 | Active specific immunotherapy: using tumor heterogeneity to successfully fight cancer. | Hum Vaccin Immunother | 2014 |
| 25081901 | A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. | Ann Oncol | 2014 |
| 23384718 | A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma. | Oral Oncol | 2013 |
| 23773728 | Notch signaling mediates melanoma-endothelial cell communication and melanoma cell migration. | Pigment Cell Melanoma Res | 2013 |
| 23384718 | A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma. | Oral Oncol | 2013 |
| 23773728 | Notch signaling mediates melanoma-endothelial cell communication and melanoma cell migration. | Pigment Cell Melanoma Res | 2013 |
| 22020057 | Therapeutic targets in head and neck squamous cell carcinoma: identification, evaluation, and clinical translation. | Oral Oncol | 2012 |
| 22687942 | Biology of human papillomavirus-related oropharyngeal cancer. | Semin Radiat Oncol | 2012 |
| 22020057 | Therapeutic targets in head and neck squamous cell carcinoma: identification, evaluation, and clinical translation. | Oral Oncol | 2012 |
| 22687942 | Biology of human papillomavirus-related oropharyngeal cancer. | Semin Radiat Oncol | 2012 |
| 19330028 | Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. | Nat Genet | 2009 |
| 19330028 | Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. | Nat Genet | 2009 |